Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AED withdrawal after long-term seizure freedom in low-grade and anaplastic glioma
NL-OMON41523Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of temozolomide in epilepsy and glioma (2 arms), sponsored by Vrije University Medical Center. Primary endpoints: Rate of successful AED withdrawal, Physician decision to continue AEDs and 5 more. Started Jan 2014; status: active, not recruiting.
02
Drugs
temozolomide
03
Conditions
epilepsyglioma
Beyond the preview
Go deeper on NL-OMON41523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41523.